Volume 26, Issue 1p2 pp. 257-263

Relationship Between Selected Overdrive Parameters and the Therapeutic Outcome and Tolerance of Atrial Overdrive Pacing

PATRICK ATTUEL

PATRICK ATTUEL

Center Médico-chirurgical Parly 2, Le Chesnay, France

Search for more papers by this author
DEJAN DANILOVIC

DEJAN DANILOVIC

Clinical Department, Biotronik GmbH & Co., Erlangen, Germany

Search for more papers by this author
KARL-HEINZ KONZ

KARL-HEINZ KONZ

Medical Clinic II, St. Franziskus Hospital, Maria Hilf Clinics, Moenchengladbach, Germany

Search for more papers by this author
JOHANNES BRACHMANN

JOHANNES BRACHMANN

Medical Clinic II, Coburg Clinics gGmbH, Coburg, Germany

Search for more papers by this author
DIA EL ALLAF

DIA EL ALLAF

Hutois Hospital Center, Huy, Belgium

Search for more papers by this author
STEFFEN LÖSCHER

STEFFEN LÖSCHER

1 st Department of Internal Medicine, St. Georg Hospital, Leipzig, Germany

Search for more papers by this author
CANDIDO GOMES

CANDIDO GOMES

Heart Institute Incore, Taguatinga, Brazil

Search for more papers by this author
THOMAS SCHEIBNER

THOMAS SCHEIBNER

Internistic-Cardiology Practice, Löbau, Germany

Search for more papers by this author
VOLKER SCHIBGILLA

VOLKER SCHIBGILLA

Medical Clinic II, Coburg Clinics gGmbH, Coburg, Germany

Search for more papers by this author
ISTVAN SZENDEY

ISTVAN SZENDEY

Center Médico-chirurgical Parly 2, Le Chesnay, France

Search for more papers by this author
ANDREAS HARTMANN

ANDREAS HARTMANN

1 st Department of Internal Medicine, St. Georg Hospital, Leipzig, Germany

Search for more papers by this author
on behalf of the “Suppression of Atrial Fibrillation by DDD+ Overdrive Pacing with Inos2 CLS Pacemakers” study investigators

on behalf of the “Suppression of Atrial Fibrillation by DDD+ Overdrive Pacing with Inos2 CLS Pacemakers” study investigators

Center Médico-chirurgical Parly 2, Le Chesnay, France

Search for more papers by this author
First published: 28 March 2003
Citations: 4
Address for reprints: Patrick Attuel, M.D., Centre Médico-chirurgical Parly 2, 21 rue Moxouris, F-78150 Le Chesnay, France. Fax: +33-1-565-97-105.

The study was sponsored by Biotronik GmbH & Co., Berlin, Germany.

Abstract

ATTUEL, P., et al. : Relationship Between Selected Overdrive Parameters and the Therapeutic Outcome and Tolerance of Atrial Overdrive Pacing. There is a paucity of information on the influence of selected overdrive parameters on the clinical efficacy and tolerance of atrial overdrive algorithms to suppress atrial tachyarrhythmias. Data from a completed clinical trial investigating a new DDD+ overdrive algorithm implemented in a permanent pacemaker were analyzed. One-hundred patients with standard pacing indications and atrial tachyarrhythmias were enrolled and followed for 6 months in DDD and 6 months in DDD+ mode in a randomized, crossover fashion. The overdrive step size was programmed at the discretion of the investigators between 4 and 12 beats/min, overdrive plateau length between 10 and 32 beats, and maximum overdrive rate between 100 and 160 beats/min. The effects of DDD+ versus DDD mode on burden and incidence of atrial tachyarrhythmias stored in the mode switch memory were examined as a function of the programmed overdrive parameters. An overdrive step size between 7 and 12 beats/min, and higher a maximum overdrive rate between 121 and 160 beats/min were slightly more effective than lower programmed values, though >500 randomized, crossover observations would have been necessary to verify statistical significance. Overdrive pacing related symptoms mandated early manual deactivation of overdrive pacing in 4.7% of 85 evaluated patients. Overdrive was disabled without testing tolerability of less aggressive overdrive values. There was no link between patient symptoms and programmed overdrive step size or overdrive plateau length values. (PACE 2003; 26[Pt. II]:257–263)

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.